Sec Form 13G Filing - Red Tree GP LLC filing for BICARA THERAPEUTICS INC (BCAX) - 2024-09-26

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. )*

 

Bicara Therapeutics, Inc.

(Name of Issuer)

 

Common stock, $0.0001 par value per share

(Title of Class of Securities)

 

055477103

(CUSIP Number)

 

September 16, 2024

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨Rule 13d-1(b)

 

xRule 13d-1(c)

 

¨Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No.   055477103
1. Names of Reporting Persons
Red Tree Venture Fund, L.P.
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨
    (b) x (1)
3. SEC Use Only
4. Citizenship or Place of Organization
Delaware
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5. Sole Voting Power
0
6. Shared Voting Power
3,170,509 (2)
7. Sole Dispositive Power
0
8. Shared Dispositive Power
3,170,509 (2)
9. Aggregate Amount Beneficially Owned by Each Reporting Person
3,170,509 (2)
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)    ¨
11. Percent of Class Represented by Amount in Row (9)
5.8% (3)
12. Type of Reporting Person (See Instructions)
PN
       

(1)This Schedule 13G is filed by Red Tree Venture Fund, L.P. (“Red Tree LP”), Red Tree GP, LLC (Red Tree GP”) and Heath Lukatch (“Lukatch” and, with Red Tree LP and Red Tree GP, collectively, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

 

(2)Consists of 3,170,509 shares of Common Stock held by Red Tree LP. Red Tree GP serves as the sole general partner of Red Tree LP and shares voting and dispositive power over the shares owned by Red Tree LP. Lukatch is the Managing Director of Red Tree GP and shares voting and dispositive power over the shares held by Red Tree LP.

 

(3)This percentage is calculated based upon 54,385,925 shares of Common Stock outstanding as of Se ptember 16, 2024 upon the closing of the Issuer’s initial public offering, as reported in the Issuer’s prospectus filed with the Securities and Exchange Commission (the “SEC”) on September 13, 2024.

 

 2 

 

 

CUSIP No.   055477103
1. Names of Reporting Persons
Red Tree GP, LLC
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨
    (b) x (1)
3. SEC Use Only
4. Citizenship or Place of Organization
Delaware
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5. Sole Voting Power
0
6. Shared Voting Power
3,170,509 (2)
7. Sole Dispositive Power
0
8. Shared Dispositive Power
3,170,509 (2)
9. Aggregate Amount Beneficially Owned by Each Reporting Person
3,170,509 (2)
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)    ¨
11. Percent of Class Represented by Amount in Row (9)
5.8% (3)
12. Type of Reporting Person (See Instructions)
OO
       

(1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

 

(2)Consists of 3,170,509 shares of Common Stock held by Red Tree LP. Red Tree GP serves as the sole general partner of Red Tree LP and shares voting and dispositive power over the shares owned by Red Tree LP. Lukatch is the Managing Director of Red Tree GP and shares voting and dispositive power over the shares held by Red Tree LP.

 

(3)This percentage is calculated based upon 54,385,925 shares of Common Stock outstanding as of September 16, 2024 upon the closing of the Issuer’s initial public offering, as reported in the Issuer’s prospectus filed with the SEC on September 13, 2024.

 

 3 

 

 

CUSIP No.   055477103
1. Names of Reporting Persons
Heath Lukatch
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨
    (b) x (1)
3. SEC Use Only
4. Citizenship or Place of Organization
United States
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5. Sole Voting Power
0
6. Shared Voting Power
3,170,509 (2)
7. Sole Dispositive Power
0
8. Shared Dispositive Power
3,170,509 (2)
9. Aggregate Amount Beneficially Owned by Each Reporting Person
3,170,509 (2)
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)    ¨
11. Percent of Class Represented by Amount in Row (9)
5.8% (3)
12. Type of Reporting Person (See Instructions)
IN
       

(1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

 

(2)Consists of 3,170,509 shares of Common Stock held by Red Tree LP. Red Tree GP serves as the sole general partner of Red Tree LP and shares voting and dispositive power over the shares owned by Red Tree LP. Lukatch is the Managing Director of Red Tree GP and shares voting and dispositive power over the shares held by Red Tree LP.

 

(3)This percentage is calculated based upon 54,385,925 shares of Common Stock outstanding as of September 16, 2024 upon the closing of the Issuer’s initial public offering, as reported in the Issuer’s prospectus filed with the SEC on September 13, 2024.

 

 4 

 

 

Item 1.
  (a) Name of Issuer
Bicara Therapeutics, Inc.
  (b) Address of Issuer’s Principal Executive Offices
116 Huntington Avenue, Suite 703, Boston, MA 02116
 
Item 2.
  (a) Name of Person Filing
Red Tree Venture Fund, L.P. (“Red Tree LP”)
Red Tree GP, LLC (Red Tree GP”)
Heath Lukatch (“Lukatch”)
  (b) Address of Principal Business Office or, if none, Residence
2055 Woodside Road, Suite 270, Redwood City, CA 94061.
  (c) Citizenship      
    Entities: Red Tree LP - Delaware
    Entities: Red Tree GP - Delaware
    Individuals: Lukatch - United States
  (d) Title of Class of Securities
Common Stock, $0.0001 par value (“Common Stock”)
  (e) CUSIP Number
055477103
 
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
  Not applicable
   

Item 4. Ownership
The following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1 is provided as of September 26, 2024:

 

Reporting
Persons
  Shares Held
Directly
   Sole
Voting
Power
   Shared
Voting
Power
   Sole
Dispositive
Power
   Shared
Dispositive
Power
   Beneficial
Ownership
   Percentage
of Class (2)
 
Red Tree LP (1)   3,170,509    0    3,170,509    0    3,170,509    3,170,509    5.8%
Red Tree GP (1)   0    0    3,170,509    0    3,170,509    3,170,509    5.8%
Lukatch (1)   0    0    3,170,509    0    3,170,509    3,170,509    5.8%

 

(1)Consists of 3,170,509 shares of Common Stock held by Red Tree LP. Red Tree GP serves as the sole general partner of Red Tree LP and shares voting and dispositive power over the shares owned by Red Tree LP. Lukatch is the Managing Director of Red Tree GP and shares voting and dispositive power over the shares held by Red Tree LP.
(2)This percentage is calculated based upon 54,385,925 shares of Common Stock outstanding as of September 16, 2024 upon the closing of the Issuer’s initial public offering, as reported in the Issuer’s prospectus filed with the SEC on September 13, 2024.

 

Item 5. Ownership of Five Percent or Less of a Class
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following    ¨

 

 5 

 

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person
  Not applicable
 
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
  Not applicable
 
Item 8. Identification and Classification of Members of the Group
  Not applicable
 
Item 9. Notice of Dissolution of Group
  Not applicable
 
Item 10. Certification
  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

 

 6 

 

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: of September 26, 2024  
     
Red Tree Venture Fund, L.P.  
     
By: Red Tree GP, LLC  
its General Partner  
     
By: /s/ Heath Lukatch  
  Name: Heath Lukatch  
  Title: Managing Director  
     
Red Tree GP, LLC  
     
By: /s/ Heath Lukatch  
  Name: Heath Lukatch  
  Title: Managing Director  
     
/s/ Heath Lukatch  
Heath Lukatch  

 

  ATTENTION  
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

 

 7 

 

 

Exhibit(s):

 

AJoint Filing Agreement

 

 8 

 

 

EXHIBIT A

 

JOINT FILING AGREEMENT

 

We, the undersigned, hereby express our agreement that the attached Schedule 13G (or any amendments thereto) relating to the Common Stock of Bicara Therapeutics, Inc. is filed on behalf of each of us.

 

Dated: of September 26, 2024  
     
Red Tree Venture Fund, L.P.  
     
By: Red Tree GP, LLC  
its General Partner  
     
By: /s/ Heath Lukatch  
  Name: Heath Lukatch  
  Title: Managing Director  
     
Red Tree GP, LLC  
     
By: /s/ Heath Lukatch  
  Name: Heath Lukatch  
  Title: Managing Director  
     
/s/ Heath Lukatch  
Heath Lukatch